Yifan Xinfu Pharmaceutical Co Ltd Total Assets
Yifan Xinfu Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) holds total assets worth CN¥12.85 Billion CNY (≈ $1.88 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 002019 market cap overview for the company's overall valuation and market capitalisation.
Total Assets of Yifan Xinfu Pharmaceutical Co Ltd (2001–2025)
Total assets of Yifan Xinfu Pharmaceutical Co Ltd from 2001 to 2025. This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Yifan Xinfu Pharmaceutical Co Ltd for real-time trading data and today's change.
Yifan Xinfu Pharmaceutical Co Ltd - Asset Composition Analysis
Yifan Xinfu Pharmaceutical Co Ltd Total Assets Breakdown (December 2025)
Yifan Xinfu Pharmaceutical Co Ltd total assets breakdown as of December 2025. Yifan Xinfu Pharmaceutical Co Ltd's total assets of CN¥12.85 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 5.7% |
| Accounts Receivable | CN¥1.40 Billion | 10.9% |
| Inventory | CN¥1.26 Billion | 9.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥2.38 Billion | 18.5% |
| Goodwill | CN¥2.74 Billion | 21.3% |
Asset Composition Trend (2001–2025)
This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Yifan Xinfu Pharmaceutical Co Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yifan Xinfu Pharmaceutical Co Ltd's current assets represent 30.5% of total assets in 2025, a decrease from 51.8% in 2001.
- Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, down from 16.2% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, an increase from 1.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 21.3% of total assets.
Yifan Xinfu Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Yifan Xinfu Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Merck & Company Inc
NYSE:MRK
|
USA | $129.80 Billion |
|
AstraZeneca PLC
NASDAQ:AZN
|
USA | $114.02 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$201.13 Billion |
|
Novartis AG
MX:NVSN
|
Mexico | MX$118.53 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $201.13 Billion |
|
Novo Nordisk A/S
CO:NOVO-B
|
Denmark | Dkr542.90 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
|
India | Rs5.47 Billion |
Yifan Xinfu Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.34 | 1.37 | 1.66 |
| Quick Ratio | 0.93 | 0.98 | 1.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥975.20 Million | CN¥1.05 Billion | CN¥1.45 Billion |
Yifan Xinfu Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yifan Xinfu Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.52 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 4.6% |
| Total Assets | CN¥12.85 Billion |
| Market Capitalization | $1.70 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yifan Xinfu Pharmaceutical Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Yifan Xinfu Pharmaceutical Co Ltd's assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Yifan Xinfu Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual total assets of Yifan Xinfu Pharmaceutical Co Ltd from 2001 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥12.85 Billion ≈ $1.88 Billion |
+4.55% |
| 2024-12-31 | CN¥12.29 Billion ≈ $1.80 Billion |
+6.84% |
| 2023-12-31 | CN¥11.50 Billion ≈ $1.68 Billion |
-8.33% |
| 2022-12-31 | CN¥12.54 Billion ≈ $1.84 Billion |
+3.11% |
| 2021-12-31 | CN¥12.17 Billion ≈ $1.78 Billion |
+3.93% |
| 2020-12-31 | CN¥11.71 Billion ≈ $1.71 Billion |
+5.78% |
| 2019-12-31 | CN¥11.07 Billion ≈ $1.62 Billion |
+13.21% |
| 2018-12-31 | CN¥9.77 Billion ≈ $1.43 Billion |
+11.49% |
| 2017-12-31 | CN¥8.77 Billion ≈ $1.28 Billion |
+25.55% |
| 2016-12-31 | CN¥6.98 Billion ≈ $1.02 Billion |
+53.59% |
| 2015-12-31 | CN¥4.55 Billion ≈ $665.33 Million |
+36.35% |
| 2014-12-31 | CN¥3.33 Billion ≈ $487.97 Million |
+395.39% |
| 2013-12-31 | CN¥673.14 Million ≈ $98.50 Million |
-36.59% |
| 2012-12-31 | CN¥1.06 Billion ≈ $155.34 Million |
-8.98% |
| 2011-12-31 | CN¥1.17 Billion ≈ $170.66 Million |
-2.93% |
| 2010-12-31 | CN¥1.20 Billion ≈ $175.81 Million |
+5.35% |
| 2009-12-31 | CN¥1.14 Billion ≈ $166.89 Million |
+33.19% |
| 2008-12-31 | CN¥856.27 Million ≈ $125.30 Million |
-3.18% |
| 2007-12-31 | CN¥884.42 Million ≈ $129.42 Million |
+49.30% |
| 2006-12-31 | CN¥592.38 Million ≈ $86.68 Million |
+14.59% |
| 2005-12-31 | CN¥516.94 Million ≈ $75.65 Million |
+44.12% |
| 2004-12-31 | CN¥358.70 Million ≈ $52.49 Million |
+80.22% |
| 2003-12-31 | CN¥199.04 Million ≈ $29.13 Million |
+50.83% |
| 2002-12-31 | CN¥131.96 Million ≈ $19.31 Million |
+51.04% |
| 2001-12-31 | CN¥87.37 Million ≈ $12.78 Million |
-- |
About Yifan Xinfu Pharmaceutical Co Ltd
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more